| Name | KTX-951 |
|---|
| Description | KTX-951 is an IRAK4 degrader (DC50=18 nM). KTX-951 (10 mg/kg) shows the oral bioavailability (F%) of 22% in a rat model. KTX-951 has good anticancer potential[1]. |
|---|---|
| Related Catalog | |
| Target |
IRAK4[1]. |
| References |
| Molecular Formula | C46H52F2N8O6 |
|---|---|
| Molecular Weight | 850.95 |